Toenail selenium levels and the subsequent risk of prostate cancer: A prospective cohort study

Cancer Epidemiology Biomarkers and Prevention

Volumn 12, Issue 9, 2003, Pages 866-871

  Van den Brandt, Piet A ^a   Zeegers, Maurice P A ^a   Bode, Peter ^b   Goldbohm, R Alexandra ^c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b DELFT UNIVERSITY OF TECHNOLOGY   (Netherlands)

^c TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; BETA CRYPTOXANTHIN; CAROTENOID; CRYPTOXANTHIN; LYCOPENE; SELENIUM; UNCLASSIFIED DRUG; XANTHOPHYLL; ZEAXANTHIN;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG TISSUE LEVEL; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NAIL; NETHERLANDS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUESTIONNAIRE; RISK FACTOR; SELENIUM TOENAIL LEVEL; SMOKING;

AGED; ANTIOXIDANTS; ASCORBIC ACID; BETA CAROTENE; CAROTENOIDS; COHORT STUDIES; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NAILS; NETHERLANDS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; QUESTIONNAIRES; RISK FACTORS; SELENIUM; SMOKING; VITAMIN E; XANTHOPHYLLS;

EID: 0141675027     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Knekt, P., Aromaa, A., Maatela, J., Alfthan, G., Aaran, R. K., Hakama, M., Hakulinen, T., Peto, R., and Teppo, L. Serum selenium and subsequent risk of cancer among Finnish men and women. J. Natl. Cancer Inst., 82: 864-868, 1990.
2. Rotruck, J. T., Pope, A. L., Ganther, H. E., Swanson, A. B., Hafeman, D. G., and Hoekstra, W. G. Selenium: biochemical role as a component of glutathione peroxidase. Science (Wash. DC), 179: 588-590, 1973.
3. Combs, G. F. Selenium. In: T. E. Moon and M. S. Micozzi (eds.), Nutrition and Cancer Prevention, Investigating the Role of Micronutrients, pp. 389-420. New York, NY: Marcel Dekker, 1989.
4. Schrauzer, G. N., White, D. A., and Schneider, C. J. Cancer mortality correlation studies-III: statistical associations with dietary selenium intakes. Bioinorg. Chem., 7: 23-31, 1977.
5. Clark, L. C., Combs, G. F., Jr., Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongrad, A., Lesher, J. L., Jr., Park, H. K., Sanders, B. B., Jr., Smith, C. L., and Taylor, J. R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA, 276: 1957-1963, 1996.
6. Clark, L. C., and Marshall, J. R. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia. Urology, 57: 185-187, 2001.
7. Klein, E. A., Thompson, I. M., Lippman, S. M., Goodman, P. J., Albanes, D., Taylor, P. R., and Coltman, C. SELECT: the next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J. Urol., 166: 1311-1315, 2001.
8. Platz, E. A., and Helzlsouer, K. J. Selenium, zinc, and prostate cancer. Epidemiol. Rev., 23: 93-101, 2001.
9. Levander, O. A. Considerations on the assessment of selenium status. Fed. Proc., 44: 2579-2583, 1985.
10. Willett, W. Nutritional Epidermology. New York: Oxford University Press, 1990.
11. Morris, J. S., Stampfer, M. J., and Willett, W. Dietary selenium in humans: toenails as an indicator. Biol. Trace. Elem. Res., 5: 529-537, 1983.
12. Hunter, D. J., Morris, J. S., Chute, C. G., Kushner, E., Colditz, G. A., Stampfer, M. J., Speizer, F. E., and Willett, W. C. Predictors of selenium concentration in human toenails. Am. J. Epidemiol., 132: 114-122, 1990.
13. Swanson, C. A., Longnecker, M. P., Veillon, C., Howe, M., Levander, O. A., Taylor, P. R., McAdam, P. A., Brown, C. C., Stampfer, M. J., and Willett, W. C. Selenium intake, age, gender, and smoking in relation to indices of selenium status of adults residing in a seleniferous area. Am. J. Clin. Nutr., 52: 858-862, 1990.
14. Yoshizawa, K., Willett, W. C., Morris, S. J., Stampfer, M. J., Spiegelman, D., Rimm, E. B., and Giovannucci, E. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J. Natl. Cancer Inst., 90: 1219-1224, 1998.
15. Nomura, A. M., Lee, J., Stemmermann, G. N., and Combs, G. F., Jr. Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol. Biomark. Prev., 9: 883-887, 2000.
16. Helzlsouer, K. J., Huang, H. Y., Alberg, A. J., Hoffman, S., Burke, A., Norkus, E. P., Morris, J. S., and Comstock, G. W. Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer. J. Natl. Cancer Inst., 92: 2018-2023, 2000.
17. Goodman, G. E., Schaffer, S., Bankson, D. D., Hughes, M. P., and Omenn, G. S. Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol. Biomark. Prev., 10: 1069-1076, 2001.
18. Brooks, J. D., Metter, E. J., Chan, D. W., Sokoll, L. J., Landis, P., Nelson, W. G., Muller, D., Andres, R., and Carter, H. B. Plasma selenium level before diagnosis and the risk of prostate cancer development. J. Urol., 166: 2034-2038, 2001.
19. Hartman, T. J., Albanes, D., Pietinen, P., Hartman, A. M., Rautalahti, M., Tangrea, J. A., and Taylor, P. R. The association between baseline vitamin E, selenium, and prostate cancer in the α-tocopherol, β-carotene cancer prevention study. Cancer Epidemiol. Biomark. Prev., 7: 335-340, 1998.
20. Key, T. J., Silcocks, P. B., Davey, G. K., Appleby, P. N., and Bishop, D. T. A case-control study of diet and prostate cancer. Br. J. Cancer, 76: 678-687, 1997.
21. Lee, M. M., Wang, R. T., Hsing, A. W., Gu, F. L., Wang, T., and Spitz, M. Case-control study of diet and prostate cancer in China. Cancer Causes Control, 9: 545-552, 1998.
22. van 't Veer, P., van der Wielen, R. P., Kok, F. J., Hermus, R. J., and Sturmans, F. Selenium in diet, blood, and toenails in relation to breast cancer: a case-control study. Am. J. Epidemiol., 131: 987-994, 1990.
23. van den Brandt, P. A., Goldbohm, R. A., van 't Veer, P., Volovics, A., Hermus, R. J., and Sturmans, F. A large-scale prospective cohort study on diet and cancer in The Netherlands. J. Clin. Epidemiol., 43: 285-295, 1990.
24. Prentice, R. L. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika, 73: 1-11, 1988.
25. Self, S. G., and Prentice, R. L. Asymptotic distribution theory and efficieny results for case-cohort studies. Ann. Stat., 16: 64-81, 1988.
26. van den Brandt, P. A., Schouten, L. J., Goldbohm, R. A., Dorant, E., and Hunen, P. M. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int. J. Epidemiol., 19: 553-558, 1990.
27. Goldbohm, R. A., van den Brandt, P. A., and Dorant, E. Estimation of the coverage of Dutch municipalities by cancer registries and PALGA based on hospital discharge data. Tijdschr. Soc. Gezondheidsz., 72: 80-84, 1994.
28. Goldbohm, R. A., van den Brandt, P. A., Brants, H. A., van 't Veer, P., Al, M., Sturmans, F., and Hermus, R. J. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur. J. Clin. Nutr., 48: 253-265, 1994.
29. Nevo-Table. Dutch Food Composition table 1986-1987; Nederlands voedingsstoffenbestand 1986-1987. The Hague: Voorlichtingsbureau voor de Voeding, 1986.
30. Goldbohm, R. A., Brants, H. A. M., Hulshof, K. F. A. M., and van den Brandt, P. A. The contribution of various foods to intake of vitamin A and carotenoids in the Netherlands. Int. J. Vit. Nutr. Res., 68: 378-383, 1998.
31. van den Brandt, P. A., Goldbohm, R. A., van 't Veer, P., Bode, P., Hermus, R. J., and Sturmans, F. Predictors of toenail selenium levels in men and women. Cancer Epidemiol. Biomark. Prev., 2: 107-112, 1993.
32. Zeegers, M. P., Goldbohm, R. A., Bode, P., and Van Den Brandt, P. A. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol. Biomark. Prev., 11: 1292-1297, 2002.
33. Bode, P. Automation and quality assurance in the Neutron Activation Facilities in Delft. J. Radioanal. Nucl. Chem., 245: 127-132, 2000.
34. Volovics, A., and van den Brandt, P. A. Methods for the analyses of case-cohort studies. Biom. J., 2: 195-214, 1997.
35. StataCorp. Stata Statistical Software: Release 7.0: College Station, TX: Stata Corporation, 1999.
36. Barlow, W. E. Robust variance estimation for the case-cohort design. Biometrics, 50: 1064-1072, 1994.
37. Lin, D. Y., and Ying, Z. Cox regression with incomplete covariate measurements. JASA, 88: 1341-1349, 1993.
38. Schuurman, A. G., Zeegers, M. P., Goldbohm, R. A., and van den Brandt, P. A. A case-cohort study on prostate cancer risk in relation to family history of prostate cancer. Epidemiology, 10: 192-195, 1999.
39. Schuurman, A. G., Goldbohm, R. A., and van den Brandt, P. A. A prospective cohort study on consumption of alcoholic beverages in relation to prostate cancer incidence (The Netherlands). Cancer Causes Control, 10: 597-605, 1999.
40. Schuurman, A. G., van den Brandt, P. A., Dorant, E., Brants, H. A., and Goldbohm, R. A. Association of energy and fat intake with prostate carcinoma risk: results from The Netherlands Cohort Study. Cancer (Phila.), 86: 1019-1027, 1999.
41. Schuurman, A. G., Goldbohm, R. A., Dorant, E., and van den Brandt, P. A. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol. Biomark. Prev., 7: 673-680, 1998.
42. van den Brandt, P. A., Goldbohm, R. A., van 't Veer, P., Bode, P., Dorant, E., Hermus, R. J., and Sturmans, F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res., 53: 4860-4865, 1993.
43. Nomura, A., Heilbrun, L. K., Morris, J. S., and Stemmermann, G. N. Serum selenium and the risk of cancer, by specific sites: case-control analysis of prospective data. J. Natl. Cancer Inst., 79: 103-108, 1987.
44. Willett, W. C., Polk, B. F., Morris, J. S., Stampfer, M. J., Pressel, S., Rosner, B., Taylor, J. O., Schneider, K., and Hames, C. G. Prediagnostic serum selenium and risk of cancer. Lancet, 2: 130-134, 1983.
45. Longnecker, M. P., Stram, D. O., Taylor, P. R., Levander, O. A., Howe, M., Veillon, C., McAdam, P. A., Patterson, K. Y., Holden, J. M., Morris, J. S., Swanson, C. A., and Willett, W. C. Use of selenium concentration in whole blood, serum, toenails, or urine as a surrogate measure of selenium intake. Epidemiology, 7: 384-390, 1996.
46. van den Brandt, P. A., van't Veer, P., Goldbohm, R. A., Dorant, E., Volovics, A., Hermus, R. J., and Sturmans, F. A prospective cohort study on dietary fat and the risk of postmenopausal breast cancer. Cancer Res., 53: 75-82, 1993.
47. Garland, M., Morris, J. S., Rosner, B. A., Stampfer, M. J., Spate, V. L., Baskett, C. J., Willett, W. C., and Hunter, D. J. Toenail trace element levels as biomarkers: reproducibility over a 6-year period. Cancer Epidemiol. Biomark. Prev., 2: 493-497, 1993.
48. Post, P. N., Kil, P. J., Crommelin, M. A., Schapers, R. F., and Coebergh, J. W. Trends in incidence and mortality rates for prostate cancer before and after prostate-specific antigen introduction. A registry-based study in southeastern Netherlands, 1971-1995. Eur. J. Cancer, 34: 705-709, 1998.
49. Criqui, M. H., Bangdiwala, S., Goodman, D. S., Blaner, W. S., Morris, J. S., Kritchevsky, S., Lippel, K., Mebane, I., and Tyroler, H. A. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study. Ann. Epidemiol., 1: 385-393, 1991.
50. Coates, R. J., Weiss, N. S., Daling, J. R., Morris, J. S., and Labbe, R. F. Serum levels of selenium and retinol and the subsequent risk of cancer. Am. J. Epidemiol., 128: 515-523, 1988.
51. Ghadirian, P., Maisonneuve, P., Perret, C., Kennedy, G., Boyle, P., Krewski, D., Lacroix, A., Hardell, L., Degerman, A., Tomic, R., Marklund, S. L., and Bergfors, M. A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect. Prev., 24: 305-313, 2000.
52. Hardell, L., Degerman, A., Tomic, R., Marklund, S. L., and Bergfors, M. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia. Eur. J. Cancer Prev, 4: 91-95, 1995.
53. Duffield-Lillico, A. J., Reid, M. E., Turnbull, B. W., Combs, G. F. J., Slate, E. H., Fischbach, L. A., Marshall, J. R., and Clark, L. C. Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomark. Prev., 11: 630-639, 2002.
54. West, D. W., Slattery, M. L., Robison, L. M., French, T. K., and Mahoney, A. W. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors. Cancer Causes Control, 2: 85-94, 1991.
55. Jain, M. G., Hislop, G. T., Howe, G. R., and Ghadirian, P. Plant foods, antioxidants, and prostate cancer risk: findings from case-control studies in Canada. Nutr. Cancer, 34: 173-184, 1999.
56. Seo, Y. R., Sweeney, C., and Smith, M. L. Selenomethionine induction of DNA repair response in human fibroblasts. Oncogene, 21: 3663-3669, 2002.
57. Thompson, H. J., Wilson, A., Lu, J., Singh, M., Jiang, C., Upadhyaya, P., el Bayoumy, K., and Ip, C. Comparison of the effects of an organic and an inorganic form of selenium on a mammary carcinoma cell line. Carcinogenesis (Lond.), 15: 183-186, 1994.
58. el Bayoumy, K., Chae, Y. H., Upadhyaya, P., Meschter, C., Cohen, L. A., and Reddy, B. S. Inhibition of 7, 12-dimethylbenz(a)anthracene-induced tumors and DNA adduct formation in the mammary glands of female Sprague-Dawley rats by the synthetic organoselenium compound, 1, 4-phenylenebis(methylene)selenocyanate. Cancer Res., 52: 2402-2407, 1992.
59. Medina, D. Mechanisms of selenium inhibition of tumorigenesis. Adv. Exp. Med. Biol., 206: 465-472, 1986.
60. Griffin, A. C. Role of selenium in the chemoprevention of cancer. Adv. Cancer Res., 29: 419-442, 1979.
61. Redman, C., Scott, J. A., Baines, A. T., Basye, J. L., Clark, L. C., Calley, C., Roe, D., Payne, C. M., and Nelson, M. A. Inhibitory effect of selenomethionine on the growth of three selected human tumor cell lines. Cancer Lett., 125: 103-110, 1998.
62. Nakayama, T., Kaneko, M., Kodama, M., and Nagata, C. Cigarette smoke induces DNA single-strand breaks in human cells. Nature (Lond.), 314: 462-464, 1985.
63. Church, D. F., and Pryor, W. A. Free-radical chemistry of cigarette smoke and its toxicological implications. Environ. Health Perspect., 64: 111-126, 1985.
64. Anonymous. The effect of vitamin E and β carotene on the incidence of lung cancer and other cancers in male smokers. The α-Tocopherol, β Carotene Cancer Prevention Study Group. N. Engl. J. Med., 330: 1029-1035, 1994.
65. Schuurman, A. G., Goldbohm, R. A., Brants, H. A. M., and van den Brandt, P. A. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control, 13: 573-582, 2002.
66. Kolonel, L. N., Hankin, J. H., and Yoshizawa, C. N. Vitamin A and prostate cancer in elderly men: enhancement of risk. Cancer Res., 47: 2982-2985, 1987.
67. Nomura, A. M., Stemmermann, G. N., Lee, J., and Craft, N. E. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol. Biomark. Prev., 6: 487-491, 1997.
68. Giovannucci, E., Rimm, E. B., Liu, Y., Stampfer, M. J., and Willett, W. C. A prospective study of tomato products, lycopene, and prostate cancer risk. J. Natl. Cancer Inst., 94: 391-398, 2002.